Han Chu Lee
Overview
Explore the profile of Han Chu Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
248
Citations
5967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chung S, Kim J, Choi W, Choi J, Lee D, Shim J, et al.
Clin Cancer Res
. 2025 Feb;
PMID: 39992640
Purpose: A recent trial has shown that adding transarterial chemoembolization (TACE) to lenvatinib therapy results in enhanced therapeutic efficacy in hepatocellular carcinoma (HCC). We aimed to assess the effectiveness of...
2.
Park K, Lee H, Kim E, Choi W, Lee D, Shim J, et al.
Aliment Pharmacol Ther
. 2025 Jan;
PMID: 39871662
Background And Aims: Real-world data on the variceal bleeding (VB) risk in patients receiving atezolizumab-bevacizumab (Atezo-Bev) treatment remain limited. This study aimed to assess the risk of VB and identify...
3.
Chung S, Kim Y, Lim J, Choi J, Lee D, Shim J, et al.
Am J Gastroenterol
. 2024 Dec;
PMID: 39718241
Introduction: Nationwide, population-based data on the risk of extrahepatic malignancy in patients with autoimmune hepatitis (AIH) in Asian countries are scarce. This study aimed to examine the risk of developing...
4.
Ha Y, Lee S, Lim J, Lee K, Chon Y, Lee J, et al.
Liver Int
. 2024 Dec;
45(4):e16139.
PMID: 39692285
Background And Aims: This study aims to develop and validate a machine learning (ML) model predicting hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients after the first 5 years...
5.
Song Y, Jung J, Park J, Kim S, Choi J, Lee D, et al.
J Med Imaging Radiat Oncol
. 2024 Oct;
69(1):144-152.
PMID: 39428124
Introduction: We investigated the clinical outcomes of stereotactic body radiation therapy (SBRT) alone versus SBRT after incomplete transarterial chemoembolization (TACE) for a single recurrent hepatocellular carcinoma (HCC) smaller than 5 ...
6.
Chung S, Um H, Choi W, Choi J, Lee D, Shim J, et al.
Clin Gastroenterol Hepatol
. 2024 Aug;
23(2):300-309.e9.
PMID: 39089518
Background And Aims: Whether tenofovir or entecavir has different effects on the prevention of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) in secondary and tertiary preventive settings is still a...
7.
Kim Y, Chung S, Kim M, Choi W, Choi J, Lee D, et al.
J Hepatocell Carcinoma
. 2024 Jul;
11:1235-1249.
PMID: 38974017
Introduction: We aimed to evaluate the generalizability of retrospective single-center cohort studies on prognosis of hepatocellular carcinoma (HCC) by comparing overall survival (OS) after various treatments between a nationwide multicenter...
8.
Yang J, Choi W, Lee D, Shim J, Kim K, Lim Y, et al.
J Gastroenterol Hepatol
. 2024 Jun;
39(10):2112-2119.
PMID: 38872368
Background And Aim: The steatosis-associated fibrosis estimator (SAFE) score has been developed to distinguish clinically significant fibrosis in patients with steatotic liver disease (SLD). However, validation of its performance in...
9.
Choi J, Jo C, Kim S, Ryu M, Choi W, Lee D, et al.
Clin Gastroenterol Hepatol
. 2024 May;
22(11):2240-2249.e6.
PMID: 38750867
Background & Aims: This study aims to reevaluate upper reference limit (URL) for alanine aminotransferase (ALT) by considering the changing epidemiology of major liver diseases. We employed histological and metabolic...
10.
Yang J, Choi W, Lee D, Shim J, Kim K, Lim Y, et al.
J Liver Cancer
. 2024 Apr;
24(2):178-191.
PMID: 38566326
Backgrounds/aims: This study aimed to compare the outcomes of liver resection (LR) and transarterial chemoembolization (TACE) in patients with multinodular hepatocellular carcinoma (HCC) within the Milan criteria who were not...